Back to Companies
Immix Biopharma, Inc.
IMMXNasdaqCIK: 0001873835
Over the 15 most recent insider filings, Immix Biopharma, Inc. (IMMX) has seen activity from 9 distinct insiders — all of them on the buy side. The activity is heavily weighted toward buying: $20.2K bought versus $0 sold, a net purchase of $20.2K. Morris Gabriel S (CFO, President, Director) is the most active by dollar volume, and the single largest transaction was $4.4M by Rachman Ilya M. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$10.0M
Purchases
$20.2K
Sales
$0
Unique Insiders
9
Recent Insider Trades
15 loaded
| May 29 | IMMX Immix Biopharma, Inc. | Chudnovsky Yekaterina | Director | Grant | $109.8K |
| May 29 | IMMX Immix Biopharma, Inc. | Marquet Magda | Director | Grant | $109.8K |
| May 29 | IMMX Immix Biopharma, Inc. | Hsu Jason | Director | Grant | $109.8K |
| May 29 | IMMX Immix Biopharma, Inc. | Rachman Ilya M | CEO and Chairman, Director | Award | $4.4M |
| May 29 | IMMX Immix Biopharma, Inc. | CHANG NANCY T | Director | Grant | $109.8K |
| May 29 | IMMX Immix Biopharma, Inc. | Morris Gabriel S | CFO, President, Director | Award | $4.4M |
| May 29 | IMMX Immix Biopharma, Inc. | Adams Helen C. | Director | Grant | $109.8K |
| May 29 | IMMX Immix Biopharma, Inc. | Ng Carey | Director | Grant | $109.8K |
| May 29 | IMMX Immix Biopharma, Inc. | BUCHAN JANE | Director | Grant | $109.8K |
| Dec 10 | IMMX Immix Biopharma, Inc. | Rachman Ilya M | CEO and Chairman, Director | Buy | $5.0K |
| Dec 10 | IMMX Immix Biopharma, Inc. | Morris Gabriel S | CFO, Director | Buy | $5.1K |
| Dec 11 | IMMX Immix Biopharma, Inc. | CHANG NANCY T | Director | Award | $171.7K |
| Sep 17 | IMMX Immix Biopharma, Inc. | Rachman Ilya M | CEO and Chairman, Director | Buy | $5.0K |
| Sep 17 | IMMX Immix Biopharma, Inc. | Morris Gabriel S | CFO, Director | Buy | $5.1K |
| Sep 17 | IMMX Immix Biopharma, Inc. | CHANG NANCY T | Director | Other | $0 |
15 filings